VIT

VITURA FPO [VIT]
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a therapy clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; Adaya, which provides hybrid formulations and Australian-cultivated products; Candor Medical, that provides care to patients; and inscape, which offers crafted formulations for individual needs. In addition, the company engages in the supply of MDMA and synthetic psilocybin for therapeutic purposes. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.
Healthcare · ASX Small Cap
$0.0210 +0.0%

Updated 9 Sep 2026 · Signals refresh every scan

Appeared in 3 consecutive scansFirst seen: 2026-02-26
Get alerts when VIT triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track VIT — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • MACD momentum is losing steam
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Volume surging at 17.1x normal while price falls — heavy selling pressure
  • Sitting near support — this level has held before and could attract buyers again
  • Took a hit — down 22.2% over the last 5 days
  • Lagging the Small Ords index — relative strength of 0.90, underperforming its peers
  • Strong cash runway (235 quarters)
  • Low P/S ratio (0.1x)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (2% of range)
  • Micro-cap ($5-20M) - high risk
  • CANSLIM S: Tight float (35%)
  • Sentiment is mixed — no strong consensus either way
  • This one has been in freefall — down 61% over the past year
  • Poor risk-adjusted returns — Sharpe of -1.5 means lots of volatility for not much reward
  • Low-priced stock risk ($0.022)
  • RBA hiking (-3pts)
  • Calendar: Clinical Trial in 6d (+5pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Negative profit margins (-3%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • The bigger volume days are the down days — volume-weighted momentum is negative (-4.72%/day)

Expected next for VIT

15 Sep 2026Clinical Trial UpdateCompany-indicated window
Window: 1 Jul to 31 Dec
From a company announcement on 25 Feb 2026
The last 1 moved VIT +1.2% on the day, on average — an observation, not a guide to what happens next.
Each date is labelled with how it is known. A date estimated from past filings is inferred from this company's own filing rhythm — it is not a confirmed date and not a statement about what the company intends to do. See the whole ASX calendar →

Recent Catalysts

NONE Doctors on Demand Update
NONE Investor Webinar and presentation
NONE FY2026 Financial Results

Recent ASX Announcements

2026-09-07 Doctors on Demand Update PRICE SENSITIVE
2026-08-25 Investor Webinar and presentation
2026-08-25 FY2026 Financial Results PRICE SENSITIVE
2026-08-25 ASX Appendix 4G Corporate Governance Principles
2026-08-25 2026 Financial Report

Key Metrics

$14.6M
Market Cap
435K
Avg Volume
17.1x
Vol Ratio
$0.02 — $0.07
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-9.7%
ROE
-3.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 35%
LLeader vs LaggardlaggardRS: -18
IInstitutional SponsorshipweakInst: 1%
MMarket DirectionneutralNeutral

Sector: Healthcare

110 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
NUZ +37.1%IPD +20.0%HIQ +16.7%AVE +15.0%CVB +11.1%
Compare:VIT vs NUZVIT vs IPDVIT vs HIQ
Share this analysis

Track VIT and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required